Potentially great place to work. - werkgeversreview Health Economist bij Genentech

4,0
23 aug 2008
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

-Oncology product line -Great science -Hot company, great brand name -Generally good people can be found across the company in various divisions

Minpunten

Corporatization and growth. Trend of commercial dictating development too much. Potential buyout by Roche. The other thing to be aware of is the changing nature of the biopharma field in conjunction with the changing landscape of health system in the US. Biotech drugs are garnering increasing scrutiny due to price and companies like Genentech will be pushed to demonstrate value above and beyond what it has done so far. With regards to this the free ride is over.

Ontdek andere reviews over Genentech

5,0
6 jun 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Great salary and team! The interview process was smooth and effective.

Minpunten

To be determined, but so far many alignment meetings. Some folks have frustuations around the re-org and strategy changes.

2,0
19 jun 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

The work is meaningful and overall the company vision aligns with my goals

Minpunten

QA management has become inept. None of the leadership (aside from maybe one or two) truly understand the nuances of our site and jobs. They refuse to pay you more due to "budget" reasons but won't provide much information, they claim to be transparent but will make decisions behind your back and not communicate them, even if they impact you and/or your job. Leadership doesn't listen to feedback and gets defensive if you even try to give any. It honestly has become a game of politics only in QA and that's not really building any real quality culture.

Bekijk reviews op: Nuttig|Beoordeling|Datum|Alle